Furthermore, GUT-70 is capable of down-regulating the expression of CD4, CCR5, and CXCR4 receptors on the cell surface in a dose-dependent manner, therefore representing a starting point for the development of novel tools against HIV-1 infection [38]. This evidence concerns the gene CCR5 and HIV-1 infection.